A new minimally invasive treatment option called cystoscopic laser lithotripsy is changing the game for pets with bladder and ...

A new minimally invasive treatment option is changing the game for pets with bladder and urethral stones. The UI Teaching ...

ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...

Gene one of nine companies awarded CDRP per yearProgram aims to support CMC development of products with expedited clinical development timeframes and provide patients with earlier access to these ...

ImmunityBio delivered strong 3Q25 results, with Anktiva driving 434% YoY product revenue growth and a narrowed operating loss ...

Kenall Manufacturing's recently launched MedMaster Saturntm luminaire has been awarded 2025 Product Innovation Awards (PIAs) by both Interiors + Sources (i+s) and Architectural Products magazines, ...

Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses([1]) , while ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...

Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...

Baystreet.ca News Commentary – The 2025 American Society of Hematology meeting showcased pivotal advances in blood cancer treatment, with novel immunotherapies and bispecific antibodies ...